Literature DB >> 2906731

Production, purification, and assay of Clostridium perfringens enterotoxin.

J L McDonel, B A McClane.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2906731     DOI: 10.1016/s0076-6879(88)65018-x

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  36 in total

1.  Death pathways activated in CaCo-2 cells by Clostridium perfringens enterotoxin.

Authors:  Ganes Chakrabarti; Xin Zhou; Bruce A McClane
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

2.  Mapping of functional regions of Clostridium perfringens type A enterotoxin.

Authors:  P C Hanna; E U Wieckowski; T A Mietzner; B A McClane
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

3.  Noncytotoxic Clostridium perfringens enterotoxin (CPE) variants localize CPE intestinal binding and demonstrate a relationship between CPE-induced cytotoxicity and enterotoxicity.

Authors:  James G Smedley; Juliann Saputo; Jacquelyn C Parker; Mariano E Fernandez-Miyakawa; Susan L Robertson; Bruce A McClane; Francisco A Uzal
Journal:  Infect Immun       Date:  2008-05-27       Impact factor: 3.441

4.  Evidence that membrane rafts are not required for the action of Clostridium perfringens enterotoxin.

Authors:  Justin A Caserta; Martha L Hale; Michel R Popoff; Bradley G Stiles; Bruce A McClane
Journal:  Infect Immun       Date:  2008-09-22       Impact factor: 3.441

5.  Deletion analysis of the Clostridium perfringens enterotoxin.

Authors:  J F Kokai-Kun; B A McClane
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

6.  Molecular cloning of the 3' half of the Clostridium perfringens enterotoxin gene and demonstration that this region encodes receptor-binding activity.

Authors:  P C Hanna; A P Wnek; B A McClane
Journal:  J Bacteriol       Date:  1989-12       Impact factor: 3.490

7.  Potential Therapeutic Effects of Mepacrine against Clostridium perfringens Enterotoxin in a Mouse Model of Enterotoxemia.

Authors:  Mauricio A Navarro; Archana Shrestha; John C Freedman; Juliann Beingesser; Bruce A McClane; Francisco A Uzal
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

8.  Synergistic effects of Clostridium perfringens enterotoxin and beta toxin in rabbit small intestinal loops.

Authors:  Menglin Ma; Abhijit Gurjar; James R Theoret; Jorge P Garcia; Juliann Beingesser; John C Freedman; Derek J Fisher; Bruce A McClane; Francisco A Uzal
Journal:  Infect Immun       Date:  2014-04-28       Impact factor: 3.441

9.  Characterization of membrane-associated Clostridium perfringens enterotoxin following pronase treatment.

Authors:  E U Wieckowski; J F Kokai-Kun; B A McClane
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

10.  Evidence that a region(s) of the Clostridium perfringens enterotoxin molecule remains exposed on the external surface of the mammalian plasma membrane when the toxin is sequestered in small or large complexes.

Authors:  J F Kokai-Kun; B A McClane
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.